Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GAMAMIK NT-TAB
- Development stage
- Unknown
- Lead developer
- Vin Medicament
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
GAMAMIK NT-TAB is an oral combination pharmaceutical product marketed by Vin Medicament for the management of pain and inflammatory conditions, specifically targeting neuropathic pain. The medication consists of two active small molecule ingredients: gabapentin and nortriptyline. Gabapentin acts by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing the release of excitatory neurotransmitters. Nortriptyline, a tricyclic antidepressant, complements this action by inhibiting the reuptake of norepinephrine and serotonin, enhancing descending inhibitory pain pathways. This dual-action approach is commonly utilized for chronic conditions such as diabetic peripheral neuropathy and postherpetic neuralgia.
- Brand names
- GAMAMIK NT-TAB
02
Targets
SERT (Sodium-dependent serotonin transporter)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)NET (Norepinephrine Transporter)
Beyond the preview
Go deeper on GAMAMIK NT-TAB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GAMAMIK NT-TAB.